Abiopharma

(99% Neutral) VERTEX PHARMACEUTICALS INC / MA (VRTX) Reports Q3 2022 Financial Results

(99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K)

(99% Neutral) Genmab (GMAB) Files Form 6-K

(70% Positive) ChemoCentryx, Inc. (CCXI) Provides Update on Earlier for her career

(10% Negative) Precigen, Inc. (PGEN) Announces Delay in anticipated Development Timeline Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations

(30% Negative) Denali Therapeutics Inc. (DNLI) Announces Regulatory Update

(90% Positive) IVERIC bio, Inc. (ISEE) Announces Enrollment Update for plan Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(99% Neutral) Dyne Therapeutics, Inc. (DYN) Announces Clinical Development Update

(10% Negative) Syros Pharmaceuticals, Inc. (SYRS) Announces Business Combination

(70% Positive) BELLUS Health Inc (the company became a subdivision of the company GSK (NYSE: GSK)) (BLU) Files Form 6-K